Bio-Path Holdings, Inc. (BPTH) Social Stream



Bio-Path Holdings, Inc. (BPTH): $1.26

0.23 (-15.44%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

D

Add BPTH to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#168 of 334

in industry

Featured Post From StockTwits About BPTH

Will post Telegram to join my team once posts complete, follow and don’t miss out! Have a blessed weekend!

$BPTH
Market Price - $6.50 (up 20% since last alert)
Average Hold - $16
Accumulate - Sub $6 (raised from $5.75)
Price Target - $7.50
Estimated Time Hold - 1Q
Support - $5, $5.75
Floor - $5
Double Down Target - Sub $5.25
Option - N/A
Micro DD - June 22nd announced that the United States Patent and Trademark Office has granted a new patent relating to the Company’s BP1003 program. Provides Protection and Highlights Novelty of BP1003 to Inhibit STAT3 Expression in a Variety of Difficult to Treat Cancers. At Q1's end, a total of 3 of the hedge funds were long this stock, a change of 200% from one quarter earlier. They reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $(0.39) by 33.33 percent.
Team_Bullish, published August 14, 2021

Loading social stream, please wait...


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!